Le Lézard
Classified in: Health
Subject: SVY

Membrane Bioreactor Systems Market in the KSA, UAE and Iran, 2017


LONDON, Oct. 18, 2017 /PRNewswire/ -- Increased policy support for water recycling and reuse technologies. MBR systems are direct beneficiaries and trend is set to accelerate rapidly over the future

Download the full report: https://www.reportbuyer.com/product/5149326



Wastewater treatment, reuse and recycling are gaining prominence globally. The average length of the wastewater networks is much smaller than the water networks across regions. This shows that the Governments have focused on establishing water networks to provide clean water to various requirements.

With water mis-management, improper disposal of wastewater and low rates of water renewal, the focus is now shifting towards wastewater treatment, re-use and recycling. Membrane Bioreactors (MBR) systems for wastewater reuse and recycling are on a growth trajectory. The market is growing rapidly with China and the Middle East driving the growth momentum. Energy efficiency, an attractive payback period, and a prolonged life span are other factors adding to the growth.

Download the full report: https://www.reportbuyer.com/product/5149326

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
https://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer


These press releases may also interest you

at 13:04
Concept Medical, a pioneer in innovative drug delivery technologies, proudly announces the commencement of its groundbreaking IDE clinical study, "MAGICAL-ISR" using MagicTouch ? Sirolimus drug coated balloon (DCB), for the management of in-stent...

at 12:30
The American College of Physicians (ACP) today released an update of its 2017 guideline with clinical recommendations for the use of newer pharmacological treatments of adults with Type 2 diabetes. The clinical guideline is based on the best...

at 12:10
Pieris Pharmaceuticals, Inc. today announced that its Board of Directors has approved a 1-for-80 reverse stock split of the Company's common stock, par value $0.001, which will be effective at 5:00 pm Eastern Time on April 22, 2024. The Company's...

at 12:00
Maintaining asthma medication and asthma control leads to safer perinatal outcomes for pregnant women according to new research published in The Journal of Allergy and Clinical Immunology: In Practice (JACI: In Practice), an official journal of the...

at 11:45
Today at ACP's annual meeting, Internal Medicine Meeting 2024, Annals of Internal Medicine presented three breaking scientific research articles during a live scientific plenary session that featured the authors of those articles. The articles were...

at 11:43
- Cochlear Limited , the global leader in implantable hearing...



News published on and distributed by: